PSIAC
Sad Pill Bild Bildrechte: © spinetta / Fotolia

Oops!

Sie verwenden eine veraltete Version Ihres Internetbrowsers und können nicht auf die Inhalte der Seite zugreifen.
Bitte aktualisieren Sie Ihre Browserversion.

PSIAC

Literaturverzeichnis

Erweiterte Suche
Eradiri O. Biopharm Drug Dispos. Mar 1988; 9(2): 219-27 Pubmed [5568]
Eralp Bellibas S. Antimicrob Agents Chemother. Jul 1999; 43(7): 1815 Pubmed, Volltext [6359]
Erbe S. Psychiatr Prax. Mar 2012; 39(2): 57-63 Pubmed [3285]
Erdogan C et al. Serotonergic toxicity leading to electromyographic changes: case report. Stand Apr 2013. https://www.proquest.com/openview/ec420f391d3a7658e8ee7eab2fe809e0/1?pq-origsite=gscholar&cbl=43703 [11370]
Erdoğan C. J Neurosci Rural Pract. Jan 2013; 4(1): 57-8 Pubmed [11371]
Erdogan MA. Arch Med Sci. Nov 2018; 16(1): 205-211 Pubmed [11042]
Ereshefsky L, Jann MW, Saklad SR, Davis CM, Richard AL, Burch NR. Effects of smoking on fluphenazine clearance in psychiatric inpatients. Biol Psychiatry (1985) 20, 329-32 [928]
Ereshefsky L. Clin Pharmacokinet. Jan 1995; 29 Suppl 1: 10-8; discussion 18-9 Pubmed [4476]
Ergamisol (Levamisole). Product information. Physicians' Desk Reference (2002) 1789-91 [2142]
Ergül B. Helicobacter. Dec 2013; 18(6): 454-8 Pubmed [7668]
Erickson DA. Drug Metab Dispos. Dec 1999; 27(12): 1488-95 Pubmed [7210]
Erickson-Ridout KK. Pharmacogenet Genomics. Aug 2012; 22(8): 561-76 Pubmed, Volltext, DOI [9826]
Ericsson CD. JAMA. Apr 1982; 247(16): 2266-7 Pubmed [5622]
Eriksen J. Infect Dis (Lond). Jan 2020; : 1-35 Pubmed [8244]
Eriksson AS. Epilepsia. Aug 1996; 37(8): 769-73 Pubmed [1045]
Eriksson E. Neuropsychopharmacology. Apr 1995; 12(2): 167-76 Pubmed [12339]
Erjavec et al. J Clin Pharmacol (2000) 40, 1286-1295 [1367]
Erjavec MK. J Clin Pharmacol. Nov 2000; 40(11): 1286-95 Pubmed [7944]
Erken Pamukcu H. Anatol J Cardiol. Oct 2018; 20(4): 213-219 Pubmed, Volltext, DOI [8105]
Erle G. Eur J Clin Pharmacol. Jan 1977; 11(1): 15-8 Pubmed [809]
Ermer J. Clin Drug Investig. Apr 2013; 33(4): 243-54 Pubmed [12515]
Ermer J. Drugs R D. Jun 2015; 15(2): 175-85 Pubmed, Volltext, Springer [4532]
Ermer JC. CNS Drugs. Dec 2010; 24(12): 1009-25 Pubmed [8274]
Ernest et al. J Pharmacol Exp Ther. 2005 Feb;312(2):583-91 [3130]
Ernst Mutschler, Arzneimittelwirkungen Pharmakologie-Klinische Pharmakologie- Toxikologie, 11.. [11769]
Ernst Mutschler, Mutschler Arzneimittelwirkungen : Lehrbuch der Pharmakologie, der klinischen Pharmakologie und Toxikologie ; mit einführenden Kapiteln in die Anatomie, Physiologie und Pathophysiologie ; mit 257 Tabellen und 1417 Strukturformeln.: 207-208 [9654]
Ernstgård L. Br J Clin Pharmacol. Aug 2004; 58(2): 190-200 Pubmed, Volltext, DOI [92]
Eron JJ Jr. Lancet HIV. Dec 2018 Pubmed [8523]
Eronen M. Am J Psychiatry. Dec 2003; 160(12): 2242-3 Pubmed [8052]
Erosa SC. Curr Pain Headache Rep. Feb 2021; 25(3): 18 Pubmed [11216]
Errasti P. Transplant Proc. Feb 2002; 34(1): 137-9 Pubmed [4148]
Ersöz G. Turk J Gastroenterol. Oct 2011; 22(5): 494-9 Pubmed [4551]
Eryilmaz G. Int J Psychiatry Clin Pract. Oct 2014; 18(4): 288-92 Pubmed [667]
Erzengin M. Arch Physiol Biochem. Feb 2014; 120(1): 29-33 Pubmed [9699]
Esmaeili-Dooki MR. Iran J Pediatr. Dec 2015; 25(6): e2360 Pubmed, Volltext, DOI [7686]
Espelin DE,Done AK. Amphetamin poisoning: Effectiveness of chlorpromazine. N Engl J Med (1968) 278, 1361-65 [2059]
Espelin DE. N Engl J Med. Jun 1968; 278(25): 1361-5 Pubmed [4875]
Espinosa-Juárez JV. Drug Dev Res. May 2016; 77(3): 134-42 Pubmed [9690]
Esposito C. Biomed Pharmacother. Dec 2021; 144: 112308 Pubmed [11775]
Esposito S. Expert Opin Pharmacother. Jan 2015; 16(15): 2319-30 Pubmed [5201]
Esteban J. Drug Metab Lett. Dec 2008; 2(4): 269-79 Pubmed [7129]
Esteve Pharmaceuticals GmbH, Berlin/Deutschland. . Nov 2021 Pubmed [13235]
Estévez JA. J Antimicrob Chemother. Aug 2012; 67(8): 2013-9 Pubmed [6069]
Estrada DE. Diabetes. Dec 1996; 45(12): 1798-804 Pubmed [11728]
Etchegoyen CV. Curr Clin Pharmacol. Feb 2018 Pubmed [4871]
Etienne Y. J Heart Valve Dis. May 2011; 20(3): 348-50 Pubmed [11010]
Etogo-Asse F. Acta Gastroenterol Belg. Jan 2008; 71(1): 36-8 Pubmed [11402]
Ette EI. J Clin Pharmacol. Oct 1987; 27(10): 813-6 Pubmed [8809]
Ettinger AB. Epilepsia. Aug 2015; 56(8): 1252-63 Pubmed, Volltext, DOI [10724]
Eudaley ST. J Pharm Pract. Jul 2022; : 8971900221116009 Pubmed [12939]
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. J Hepatol. Aug 2017; 67(2): 370-398 Pubmed [7930]
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. J Hepatol. Aug 2018; 69(2): 461-511 Pubmed [7936]
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. J Hepatol. Jan 2017; 66(1): 153-194 Pubmed [7929]
Euwema MS. . Mar 2021 Pubmed [10783]
Evanger N. Can J Hosp Pharm. Nov 2017; 70(6): 463-467 Pubmed, Volltext [4957]
Evans DC. Drug Metab Dispos. Jul 2003; 31(7): 861-9 Pubmed [4640]
Evans JL. Diabetes Technol Ther. Oct 2000; 2(3): 401-13 Pubmed [11729]
Evans RL. J Clin Psychopharmacol. Oct 1990; 10(5): 355-9 Pubmed [485]
Evans RW. Headache. Jun 2010; 50(6): 1089-99 Pubmed [992]
Evans RW. MedGenMed. Sep 2007; 9(3): 48 Pubmed, Volltext [1323]
Evans SG. Trans R Soc Trop Med Hyg. Nov 1994; 88(6): 683-6 Pubmed [8722]
Evans-Prosser CD. Br J Anaesth. Apr 1968; 40(4): 279-82 Pubmed [13116]
Evers S. Eur J Neurol. Jun 2006; 13(6): 560-72 Pubmed [8475]
Evidente VG. Parkinsonism Relat Disord. Dec 2003; 10(2): 117-21 Pubmed [10437]
Evins AE. J Clin Psychopharmacol. Aug 2007; 27(4): 380-6 Pubmed [10303]
Exeltis Deutschland GmbH, Ismaning/Deutschland, Fachinformation zu XONVEA TM 10 mg/10 mg magensaftresistente Tabletten.Feb 2022 [13475]
Eyer F. Alcohol Alcohol. Mar 2011; 46(2): 177-84 Pubmed [1013]
Eyer F. J Clin Psychopharmacol. Jun 2006; 26(3): 325-30 Pubmed [9776]
Ezad S. Oxf Med Case Reports. Mar 2018; 2018(3): omx104 Pubmed, Volltext, DOI [6989]
Ezuruike U. Clin Pharmacol Ther. Dec 2018; 104(6): 1229-1239 Pubmed, Volltext, DOI [8229]
Ezzeldin N. BMC Cancer. May 2018; 18(1): 525 Pubmed, Volltext, DOI [5081]
Faaij RA. J Nutr Health Aging. Mar 2009; 13(3): 275-6 Pubmed [1687]
Fabbiani M. Pharmacol Res. Mar 2011; 63(3): 249-53 Pubmed [7359]
Fabbri M. Drugs Aging. Dec 2018; 35(12): 1041-1054 Pubmed [12211]
Fabbri M. Mov Disord. Oct 2018; 33(10): 1528-1539 Pubmed [12196]
Fabbri M. Neurodegener Dis Manag. Oct 2016; 6(5): 349-62 Pubmed [12202]
Faber ES. Drug Saf Case Rep. Dec 2016; 3(1): 14 Pubmed, Volltext, Springer [8020]
Faber MS. Basic Clin Pharmacol Toxicol. Sep 2005; 97(3): 125-34 Pubmed [3167]
Faber MS. Clin Pharmacol Ther. Aug 2004; 76(2): 178-84 Pubmed [429]
Facciolá G. Eur J Clin Pharmacol. Mar 2001; 56(12): 881-8 Pubmed [13993]
Facciolà G. Ther Drug Monit. Jun 1999; 21(3): 341-5 Pubmed [1210]
Fachi MM. Br J Clin Pharmacol. Oct 2019; 85(10): 2280-2291 Pubmed [11214]
Fachinfo Dezember 1999 [2047]
Fachinfo EMB-Fatol® [3429]
Fachinfo Noxafil (Posaconazol) [4112]
Fachinfo Phenytoin AWD 01/2009, bei Abfassung jüngste Fachinfo zu Phenytoin [2135]
Fachinfo Prezista® [3426]
Fachinfo Pyrafat® [3430]
Fachinfomation Norvasc®, Stand der Information, Oktober 2011 [3472]
Fachinforamtion Tranylcypromin 2007 [2354]
Fachinformaation Oxygesic®, Stand März 2010 [174]
Fachinformatin Sifrol April 2009 [2898]
Fachinformation [188]
Fachinformation (Glivec), Oktober 2002 [2177]
Fachinformation 04/2001 [1415]
Fachinformation 04/2002 [2123]
Fachinformation 05/2002 [2490]
Fachinformation 06/2002 [1117]
Fachinformation 08/2008 [1445]
Fachinformation 2000 [1829]